Cancer Diagnostics

Cancer is a group of diseases caused by changes in DNA. Mutations alter cell behavior, driving uncontrollable growth and malignancy. These abnormalities can take many forms, including DNA mutations, rearrangements, deletions, amplifications, and the addition or removal of chemical marks. These changes can cause cells to produce abnormal amounts of particular proteins or make misshapen proteins that do not work as they should. Often, a combination of several genomic alterations works together to promote cancer.

Once cancer-causing changes are identified, clinicians and scientists can better understand the molecular basis of cancer growth, metastasis, and drug resistance. This process is supported by our product CancerKB, which connects mutations and other biomarkers with existing FDA-approved treatment options or ongoing clinical trials.

We build a state-of-the-art diagnostic capability that allows Clinicians and Researchers to analyze tumor DNA, apply the guidelines by Association for Molecular Pathology (AMP) identifying pathogenic tumor-driving genomic aberrations. The findings are summarized in a clinical report along with all literature citations and supporting evidence.

Get in Contact

If you are interested in starting a discussion about how Golden Helix software can assist in your cancer workflow, please fill out the form below, and we will send you the details!

Recommended Learning Materials

We have a variety of supplemental learning materials that are an excellent resource for anyone interested in the industry or our software solutions. Here are some of our recommended materials for you to check out related to VarSeq!